Evidence map›Paper›PMID 27003987›Full record

SynthesisWorld journal of gastroenterology2016

Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Lynne Vernice McFarland, Metehan Ozen, Ener Cagri Dinleyici, Shan Goh

Registry-linked trialOpen access · bronzeAbstract readComparative StudySystematic Review
In one paragraph

Synthesis in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05345457 (Outpatient Antibiotics Following Previable Rupture of Membranes), which is not on this map. Cited by 68 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 5 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05345457 phase4terminatednot on this mapstarted 2023, after this paper: background citation

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

TypeinterventionalSponsorUniversity Hospitals Cleveland Medical CenterRan2023 to 2024Enrolled1ConditionsPregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy), PROM (Pregnancy)ArmsAzithromycin Pill, Amoxicillin Pill
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 5 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Global burden ofJournal of global health · 2019
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Antibiotics (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Microbiology spectrum · 2026
    Article
  13. Comparative genomic analysis ofMicrobial genomics · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  18. Observational
  19. The fitness connection of antibiotic resistance.Frontiers in microbiology · 2025
    Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Lynne Vernice McFarlandLynne Vernice McFarland, Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98108-1597, United States.
Metehan OzenLynne Vernice McFarland, Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98108-1597, United States.
Ener Cagri DinleyiciLynne Vernice McFarland, Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98108-1597, United States.
Shan GohLynne Vernice McFarland, Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98108-1597, United States.
Eskişehir Osmangazi University · TRAcıbadem University Atakent Hospital · TRSheehan Medical (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic-associated diarrhea (AAD) and Clostridium difficile infections (CDI) have been well studied for adult cases, but not as well in the pediatric population. Whether the disease process or response to treatments differs between pediatric and adult patients is an important clinical concern when following global guidelines based largely on adult patients. A systematic review of the literature using databases PubMed (June 3, 1978-2015) was conducted to compare AAD and CDI in pediatric and adult populations and determine significant differences and similarities that might impact clinical decisions. In general, pediatric AAD and CDI have a more rapid onset of symptoms, a shorter duration of disease and fewer CDI complications (required surgeries and extended hospitalizations) than in adults. Children experience more community-associated CDI and are associated with smaller outbreaks than adult cases of CDI. The ribotype NAP1/027/BI is more common in adults than children. Children and adults share some similar risk factors, but adults have more complex risk factor profiles associated with more co-morbidities, types of disruptive factors and a wider range of exposures to C. difficile in the healthcare environment. The treatment of pediatric and adult AAD is similar (discontinuing or switching the inciting antibiotic), but other treatment strategies for AAD have not been established. Pediatric CDI responds better to metronidazole, while adult CDI responds better to vancomycin. Recurrent CDI is not commonly reported for children. Prevention for both pediatric and adult AAD and CDI relies upon integrated infection control programs, antibiotic stewardship and may include the use of adjunctive probiotics. Clinical presentation of pediatric AAD and CDI are different than adult AAD and CDI symptoms. These differences should be taken into account when rating severity of disease and prescribing antibiotics.

Indexed as

AdolescentAdultAgedAge DistributionAge FactorsAnti-Bacterial AgentsChildChild, PreschoolClostridioides difficileDiarrheaEnterocolitis, PseudomembranousHumansIncidenceInfantMiddle AgedRecurrenceAnti-Bacterial AgentsAdultsAntibiotic-associated diarrheaAntibioticsClostridum difficile infectionsDiarrheaPediatricsPreventionRisk factorsTreatments

Identifiers

PMID27003987
PMCPMC4789985
OpenAlexW2312752085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.